Evidence map›Paper›PMID 40569961›Full record

ArticlePloS one2025

The influence of proteolytic enzymes on the change of lysozyme properties.

Łukasz Tomczyk, Grzegorz Leśnierowski, Aneta Tomczak, Jubilee Amajuoritse Ajemigbitse, Tomasz Szablewski, Renata Cegielska-Radziejewska

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Łukasz TomczykDepartment of Food Quality and Safety Management, Poznan University of Life Sciences, Poznan, Poland.ORCID 0000-0002-4644-0111
Grzegorz LeśnierowskiDepartment of Food Quality and Safety Management, Poznan University of Life Sciences, Poznan, Poland.
Aneta TomczakDepartment of Food Biochemistry and Analysis, Faculty of Food Science and Nutrition, Poznan University of Life Sciences, Poznan, Poland.
Jubilee Amajuoritse AjemigbitseDepartment of Food Quality and Safety Management, Poznan University of Life Sciences, Poznan, Poland.
Tomasz SzablewskiDepartment of Food Quality and Safety Management, Poznan University of Life Sciences, Poznan, Poland.
Renata Cegielska-RadziejewskaDepartment of Food Quality and Safety Management, Poznan University of Life Sciences, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research examines the enzymatic modification of lysozyme, a glycosidic hydrolase that has restricted effectiveness against Gram-negative bacteria, in order to produce bioactive peptide fractions with improved antibacterial and physicochemical characteristics. Utilizing chicken egg lysozyme, modifications were performed in controlled settings with proteolytic enzymes, mainly pepsin, and experiments with a pepsin-trypsin ratio. The modification methods sought to improve the hydrophobic nature of lysozyme's surface, create oligomeric and peptide forms, and decrease immunogenicity. Findings showed that raising pepsin concentration enhanced the creation of peptide fractions, increasing surface hydrophobicity while reducing hydrolytic and antioxidant activities. Increased hydrophobicity and reduced enzyme activity were linked to enhanced antibacterial effectiveness, particularly against Gram-negative bacteria, a characteristic absent in natural lysozyme. Additionally, the research noted a decrease in immunoreactivity as pepsin concentrations increased, achieving the lowest antibody response in optimized formulations. This enzymatic method offers an economical way to create lysozyme derivatives that hold considerable promise for wider applications, particularly in scenarios where lower immunoreactivity and a prolonged antibacterial spectrum are needed.

Indexed as

Anti-Bacterial AgentsMuramidasePeptide HydrolasesAnimalsChickensHydrophobic and Hydrophilic InteractionsMicrobial Sensitivity TestsPepsin AProteolysisAnti-Bacterial AgentsMuramidasePepsin APeptide Hydrolases

Identifiers

PMID40569961
PMCPMC12200872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.